Encompass Health Corp Files 8-K on Shareholder Votes and Reg FD
Ticker: EHC · Form: 8-K · Filed: May 6, 2024 · CIK: 785161
Sentiment: neutral
Topics: corporate-governance, regulation-fd, filing-update
Related Tickers: EHC
TL;DR
EHC filed an 8-K on May 6th for shareholder votes & Reg FD. Nothing major yet.
AI Summary
Encompass Health Corporation filed an 8-K on May 6, 2024, reporting on matters submitted to a vote of security holders and a Regulation FD disclosure. The earliest event reported was on May 2, 2024. The company, formerly known as HealthSouth Corp, is incorporated in Delaware and headquartered in Birmingham, Alabama.
Why It Matters
This filing indicates that Encompass Health Corporation held a vote of its security holders and is making a public disclosure under Regulation FD, which could impact investor understanding of recent company events.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting on shareholder votes and Regulation FD disclosures, with no immediate indication of significant financial or operational changes.
Key Numbers
- 001-10315 — SEC File Number (Identifies the company's filing with the SEC)
- 63-0860407 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Encompass Health Corporation (company) — Registrant
- HealthSouth Corp (company) — Former company name
- May 2, 2024 (date) — Earliest event reported
- May 6, 2024 (date) — Date of report
- 9001 Liberty Parkway, Birmingham, Alabama 35242 (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Encompass Health Corporation's security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in this excerpt.
What is the nature of the Regulation FD disclosure made by Encompass Health Corporation?
The filing states that a Regulation FD Disclosure was made, but the content of this disclosure is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 2, 2024.
What is Encompass Health Corporation's principal executive office address?
Encompass Health Corporation's principal executive offices are located at 9001 Liberty Parkway, Birmingham, Alabama 35242.
What were Encompass Health Corporation's former names?
Encompass Health Corporation was formerly known as HealthSouth Corp and HealthSouth Rehabilitation Corp.
Filing Stats: 861 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2024-05-06 17:10:37
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share EHC New York Stock Exchange
Filing Documents
- ehc-20240502.htm (8-K) — 44KB
- 0000785161-24-000031.txt ( ) — 166KB
- ehc-20240502.xsd (EX-101.SCH) — 2KB
- ehc-20240502_lab.xml (EX-101.LAB) — 21KB
- ehc-20240502_pre.xml (EX-101.PRE) — 12KB
- ehc-20240502_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On May 2, 2024, Encompass Health Corporation (the "Company") held its 2024 annual meeting of stockholders (the "Annual Meeting") at its principal executive office in Birmingham, Alabama. During the Annual Meeting, the stockholders of the Company voted on the following: 1. election of the 10 persons nominated by the Company's board of directors (the "Board"); 2. ratification of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm; 3. approval of the compensation of the Company's named executive officers, as disclosed in the proxy statement filed on April 2, 2024 pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and 4. stockholder proposal requesting a report on effectiveness of diversity, equity and inclusion efforts. As of the record date for the Annual Meeting, there were 100,693,390 shares of the Company's common stock issued and outstanding. Each share of common stock was entitled to one vote on each matter properly brought before the Annual Meeting. The common stock voted together as a class. Votes representing 94.4% of the combined voting power of the common stock were represented by proxy at the Annual Meeting. The final voting results for the Annual Meeting were as follows: Proposal 1, election of directors, each of the nominees was elected: Name of Nominee Votes For Votes Against Votes Abstained Greg D. Carmichael 88,073,606 1,206,413 837,171 Edward M. Christie III 88,829,119 450,779 837,292 Joan E. Herman 87,893,645 1,379,530 844,015 Leslye G. Katz 84,729,987 4,542,542 844,661 Patricia A. Maryland 88,760,994 518,399 837,797 Kevin J. O'Connor 88,536,458 743,505 837,227 Christopher R. Reidy 88,617,608 662,727 836,855 Nancy M. Schlichting 88,733,866 546,825 836,499 Mark J. Tarr 88,734,594 547,270 835,326 Terrance Williams 88,808,997 472,272 835,921 Proposal 2, ratification of the appointment of Pr
01. Regulation FD Disclosure
ITEM 7.01. Regulation FD Disclosure. Following the Annual Meeting, the Board elected Mr. Greg Carmichael as Chairman of the Board. Mr. Carmichael, currently the executive chairman of the board of directors of City National Bank, a subsidiary of Royal Bank of Canada, has served on the Company's Board since January 1, 2020. The information contained herein is being furnished pursuant to Item 7.01 of Form 8-K, "Regulation FD Disclosure." This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The furnishing of this information will not be deemed an admission as to the materiality of any information contained herein. Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ENCOMPASS HEALTH CORPORATION By: / S / Patrick Darby Name: Patrick Darby Title: Executive Vice President, General Counsel and Secretary Dated: May 6, 2024